Global Biapenem Market Size, Share and Trends Analysis Report, By Application (Sepsis, Pneumonia, Lung Abscess, and Others), Forecast Period (2022-2028)

The global biapenem market is anticipated to grow at a CAGR of 5.1% during the forecast period (2022-2028). Growing incidence of severe infections including septicemia, pneumonia, lung abscess, secondary infections of chronic respiratory diseases, complicated urinary tract infections, pyelonephritis, peritonitis and adnexitis, the global biapenem market is anticipated to grow during the forecast period. According to WHO, Pneumonia is the most common infectious cause of death in children around the globe. Pneumonia claimed the lives of 740 180 children under the age of five in 2019, accounting for 14% of all deaths in children under the age of five but 22% of all fatalities in children aged 1 to 5. In order to decrease the rate of pneumonia cases across the globe, the need for biapenem drugs rises in the market globally.

UTIs are one of the most frequent microbiological illnesses seen in medical practice, affecting persons of all ages. The global prevalence of UTIs is estimated to be over 150 million people per year. Diabetic people have a higher incidence of UTI than nondiabetic patients, as well as a higher severity of UTI, which can lead to problems ranging from dysuria (pain or burning sensation during urine) to organ damage and even death (pyelonephritis). With such a high number of cases, the demand for the drug rises. The increase in infectious diseases across the globe is going to rise the biapenem market.

Around 1 million cases of meningitis are found in India only, Meningitis is an inflammation (swelling) of the protective membranes covering the brain and spinal cord Swelling is mainly caused by a bacterial or viral infection of the fluid around the brain and spinal cord. Meningitis can also be caused by accidents, tumors, certain medicines, and other forms of infections. Therefore the market for biapenem drugs is propelling due to its high demand in the market for the forecast period.

Some major players in the market include Meiji Holdings Co., Ltd., Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd., Biodiscovery Lifesciences Pvt Ltd, Shandong Luoxin Pharmaceutical Group Stock co., ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2021, Generic pharmaceutical company BDR Pharma launched generic drug Biapenem (BIAPEN) to treat patients with intra-abdominal infections, lower respiratory infection.
Company’s Product Portfolio

• Biodiscovery Lifesciences Pvt Ltd offers Biopenem 1000mg Injection, It’s an antibiotic that’s used to treat skin, lungs, stomach, urinary tract, blood, and brain infections (eg. meningitis). It works by eliminating the microorganisms that cause these problems.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Meiji Holdings Co., Ltd., Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd., Biodiscovery Lifesciences Pvt Ltd, Shandong Luoxin Pharmaceutical Group Stock co., ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Biapenem Market Report by Segment

By Application

• Sepsis/Septicemia
• Pneumonia
• Lung Abscess
• Others (Refractory Cystitis and Pyelonephritis)

Global Biapenem Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa